StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultMar 29, 2026, 10:42 PM

Johnson & Johnson Announces Fourth Quarter and Full Year 2025 Sales and Earnings

AI Summary

Johnson & Johnson filed an 8-K announcing its sales and earnings for the fourth quarter and full year ended December 28, 2025. This provides investors with insight into the company's recent financial performance and overall health.

Key Highlights

  • The filing includes a press release (Exhibit 99.1) with details on the financial results.
  • Unaudited comparative supplementary sales data and condensed consolidated statement of earnings are provided in Exhibit 99.2.
  • The report covers the period ended December 28, 2025.